979 |
PCI in Unprotected Left Main Disease (MAIN-COMPARE, SYNTAX, and Several Registries) |
Seung-Jung Park |
May. 04. 10 |
978 |
Major Trials for Catheter-Based Coronary Interventions (SPIRIT IV, COMPARE, ZEST, ISAR-TEST4, ISAR-DESIRE 2, NORDIC-BALTIC BIFURCATION STUDY III, and PEPCAD III) |
David E. Kandzari |
May. 04. 10 |
977 |
Expert Opinion for IVUS Use in Practice (Several IVUS Registry and PROSPECT Trial) |
Akiko Maehara |
May. 04. 10 |
976 |
Practice Guideline for FFR Use (FAME Study) |
William F. Fearon |
May. 04. 10 |
975 |
PCI in Chronic Kidney Disease (RECOVER, CARE, LOCM-Related Studies, and Meta-Analysis) |
Roxana Mehran |
May. 04. 10 |
974 |
Revascularization Strategies (SYNTAX, BARI-2D, and STICH) |
David R. Holmes |
May. 04. 10 |
973 |
Stents Use in STEMI (Massachusetts Registry, NewYork Registry, Small Registries, HORIZONS-AMI, DEBATER, and GENIUS-STEMI) |
Donald E. Cutlip |
May. 04. 10 |
972 |
Triage and Transfer for PCI in STEMI (ASSENT-4, FINESSE, CARESS-in-AMI, TRANSFER-AMI, and Several Regional Systems of STEMI Care |
Christian M. Spaulding |
May. 04. 10 |
971 |
Risk-Reduction Drugs: Statin or Others (NAPLES II Trial, ARMYDA-RECAPTURE, and Other Drug-Trial Beyond Antiplatelets or Anticoagulants in ACS ) |
Anthony H. Gershlick |
May. 04. 10 |
970 |
Timing of Antiplatelet Therapy for ACS (EARLY-ACS, and ACUITY) |
Mitchell W. Krucoff |
May. 04. 10 |